Inflammopharmacology

Keyphrases

Publications

volume 32, number 4, 2024

Neveen Madbouly, Adham Ooda, Ahmed Nabil, Areej Nasser, Esraa Ahmed, Fatma Ali, Fatma Mohamed, Habiba Faried, Mai Badran, Mariam Ahmed, Mariam Ibrahim, Mariam Rasmy, Martina Saleeb, Vereena Riad, Yousr Ibrahim, Alyaa Farid
The renoprotective activity of amikacin-gamma-amino butyric acid-chitosan nanoparticles: a comparative study. Inflammopharmacology 32 (4) (2024)
Lara Panazzolo Marquezin, Maria Fernanda Pessano Fialho, Amanda Favarin, Jéssica Dotto de Lara, Micheli Mainardi Pillat, Denis Broock Rosemberg, Sara Marchesan Oliveira
Diosmetin attenuates fibromyalgia-like symptoms in a reserpine-induced model in mice. Inflammopharmacology 32 (4) (2024)
Hoda A Abd-Ellatieff, Kristen Georg, Abdel-Rahman A Abourawash, Emad W Ghazy, Dalia H Samak, Wael M Goda
Aspergillus awamori: potential antioxidant, anti-inflammatory, and anti-apoptotic activities in acetic acid-induced ulcerative colitis in rats. Inflammopharmacology 32 (4) (2024)
Almudena Rodríguez-Fernández, Irene Visos-Varela, Maruxa Zapata-Cachafeiro, Samuel Pintos-Rodríguez, Rosa María García-Álvarez, María Teresa Herdeiro, María Piñeiro-Lamas, Adolfo Figueiras, Ángel Salgado-Barreira, null null
Outpatient glucocorticoid use and COVID-19 outcomes: a population-based study. Inflammopharmacology 32 (4) (2024)
Muhammad Fiaz, Muhammad Asif, Kashif Ur Rehman Khan
Launaea fragilis extract attenuated arthritis in rats through modulation of IL-1β, TNF-α, IL-6, NF-κB, COX-2, IL-4, and IL-10. Inflammopharmacology 32 (4) (2024)
Michael Thomsen, Ravichandra Vemuri, Flavia Huygens, Stephen John Clarke, Luis Vitetta
An exploratory study of a multi-species probiotic formulation and markers of health in a real-world oncological cohort in the time of covid. Inflammopharmacology 32 (4) (2024)
Lurong Miao, Ziqi Yuan, Shijia Zhang, Guangqin Zhang
Honokiol alleviates monosodium urate-induced gouty pain by inhibiting voltage-gated proton channels in mice. Inflammopharmacology 32 (4) (2024)
Yong-Ze Yang, Qing-Hao Cheng, An-Ren Zhang, Yi Qiu, Hong-Zhang Guo
Progress in the treatment of Osteoarthritis with avocado-soybean unsaponifiable. Inflammopharmacology 32 (4) (2024)
Hitesh Malhotra, Vandana Garg, Govind Singh, Rohit Dutt
Ethanol extract of Ziziphus nummularia ameliorates formaldehyde-induced arthritis in rats by regulating oxidative stress biomarkers and haematological profile. Inflammopharmacology 32 (4) (2024)
Zhuqing Li, Yanyong Yang, Fu Gao
Monomeric compounds from natural products for the treatment of pulmonary fibrosis: a review. Inflammopharmacology 32 (4) (2024)
Amany Abd Elaal Aiad, Sahar Mohamed El-Haggar, Amal Mohamed El-Barbary, Dalia Refat El-Afify
Metformin as adjuvant therapy in obese knee osteoarthritis patients. Inflammopharmacology 32 (4) (2024)
Kasturi Dutta, Akalesh Kumar Verma, Munmi Gogoi, Mary Devi, Maishnam Rustam Singh, Namram Sushindrajit Singh
Anti-inflammatory activity of the phenol rich fraction of Garcinia pedunculata Roxb (ex. Buch Ham): an in vitro and in vivo study. Inflammopharmacology 32 (4) (2024)
Hoda A Abd-Ellatieff, Kristen Georg, Abdel-Rahman A Abourawash, Emad W Ghazy, Dalia H Samak, Wael M Goda
Aspergillus awamori: potential antioxidant, anti-inflammatory, and anti-apoptotic activities in acetic acid-induced ulcerative colitis in rats. Inflammopharmacology 32 (4) (2024)
S Rohini, Uday Raj Sharma, M Vinutha, D Shreelaxmi, Surendra Vada, Suresh Janandri, T Haribabu, Nageena Taj, S V Gayathri, Abhishek Ghara, Manjunatha P Mudagal
Rheumatoid arthritis-associated complications during pregnancy and its effect on offspring: comprehensive review. Inflammopharmacology 32 (4) (2024)
Neveen Madbouly, Adham Ooda, Ahmed Nabil, Areej Nasser, Esraa Ahmed, Fatma Ali, Fatma Mohamed, Habiba Faried, Mai Badran, Mariam Ahmed, Mariam Ibrahim, Mariam Rasmy, Martina Saleeb, Vereena Riad, Yousr Ibrahim, Alyaa Farid
The renoprotective activity of amikacin-gamma-amino butyric acid-chitosan nanoparticles: a comparative study. Inflammopharmacology 32 (4) (2024)
Michael J Parnham
Of rodents, research and relationships: a pharmacological odyssey. Inflammopharmacology 32 (4) (2024)
Amany Abd Elaal Aiad, Sahar Mohamed El-Haggar, Amal Mohamed El-Barbary, Dalia Refat El-Afify
Metformin as adjuvant therapy in obese knee osteoarthritis patients. Inflammopharmacology 32 (4) (2024)
Bhagyabhumi Shah, Solanki Nilay
Aegeline attenuates TNBS-induced colitis by suppressing the NFƙB-mediated NLRP3 inflammasome pathway in mice. Inflammopharmacology 32 (4) (2024)
Samaneh Hajimohammadi, Maryam Rameshrad, Gholamreza Karimi
Exploring the therapeutic effects of sulforaphane: an in-depth review on endoplasmic reticulum stress modulation across different disease contexts. Inflammopharmacology 32 (4) (2024)
Nabeela Tabassum Sial, Abdul Malik, Urooj Iqbal, Muhammad Fayyaz Ur Rehman
Arbutin attenuates CFA-induced arthritis by modulating expression levels of 5-LOX, NF‑κB, IL-17, PGE-2 and TNF-α. Inflammopharmacology 32 (4) (2024)
Ruonan He, Ying Li, Yi He, Qianqian Wang, Shuo Zhang, Shanshan Chen
Berberine mitigates diclofenac-induced intestinal mucosal mechanical barrier dysfunction through the restoration of autophagy by inhibiting exosome-mediated lncRNA H19. Inflammopharmacology 32 (4) (2024)
Fakhria A Al-Joufi, Ambreen Malik Uttra, Sumera Qasim, Urooj Iqbal, Nabeela Tabassum Sial, Noura M Alhumaid
Anti-arthritic and immunomodulatory efficacy of Micromeria biflora Benth extract and its fractions in rats by restoring oxidative stress, metalloproteinases, pro-inflammatory and anti-inflammatory cytokines network. Inflammopharmacology 32 (4) (2024)
Chalton Manengu, Chun-Hao Zhu, Guo-Dong Zhang, Miao-Miao Tian, Xiao-Bing Lan, Li-Jun Tao, Lin Ma, Yue Liu, Jian-Qiang Yu, Ning Liu
HDAC inhibitors as a potential therapy for chemotherapy-induced neuropathic pain. Inflammopharmacology 32 (4) (2024)
Almudena Rodríguez-Fernández, Irene Visos-Varela, Maruxa Zapata-Cachafeiro, Samuel Pintos-Rodríguez, Rosa María García-Álvarez, María Teresa Herdeiro, María Piñeiro-Lamas, Adolfo Figueiras, Ángel Salgado-Barreira, null null
Outpatient glucocorticoid use and COVID-19 outcomes: a population-based study. Inflammopharmacology 32 (4) (2024)
Babak Ebrahimi, Tahmineh Mokhtari, Neda Ghaffari, Mahdi Adabi, Gholamreza Hassanzadeh
Acellular spinal cord scaffold containing quercetin-encapsulated nanoparticles plays an anti-inflammatory role in functional recovery from spinal cord injury in rats. Inflammopharmacology 32 (4) (2024)
Anton D Van Staden
The potential of zebrafish as drug discovery research tool in immune-mediated inflammatory disease. Inflammopharmacology 32 (4) (2024)
Patrick Francis Kimariyo, Sony Priya Kurati, Samireddi Naga Venkata Durga Bhargavi, Andrew Gordon, Dickson Kayabu, Murali Krishna Kumar Muthyala
Synthesized pyrrole ester ameliorates adjuvant‑induced arthritis in Wistar rats by alleviating inflammation and downregulating the pro‑inflammatory cytokines. Inflammopharmacology 32 (4) (2024)
Michael Thomsen, Ravichandra Vemuri, Flavia Huygens, Stephen John Clarke, Luis Vitetta
An exploratory study of a multi-species probiotic formulation and markers of health in a real-world oncological cohort in the time of covid. Inflammopharmacology 32 (4) (2024)
Padmini Pai, Aradhika Vijeev, Sharada Phadke, Manasa Gangadhar Shetty, Kampa Sundara Babitha
Epi-revolution in rheumatology: the potential of histone deacetylase inhibitors for targeted rheumatoid arthritis intervention. Inflammopharmacology 32 (4) (2024)
Neveen Madbouly, Adham Ooda, Ahmed Nabil, Areej Nasser, Esraa Ahmed, Fatma Ali, Fatma Mohamed, Habiba Faried, Mai Badran, Mariam Ahmed, Mariam Ibrahim, Mariam Rasmy, Martina Saleeb, Vereena Riad, Yousr Ibrahim, Alyaa Farid
The renoprotective activity of amikacin-gamma-amino butyric acid-chitosan nanoparticles: a comparative study. Inflammopharmacology 32 (4) (2024)
Almudena Rodríguez-Fernández, Irene Visos-Varela, Maruxa Zapata-Cachafeiro, Samuel Pintos-Rodríguez, Rosa María García-Álvarez, María Teresa Herdeiro, María Piñeiro-Lamas, Adolfo Figueiras, Ángel Salgado-Barreira, null null
Outpatient glucocorticoid use and COVID-19 outcomes: a population-based study. Inflammopharmacology 32 (4) (2024)
Lurong Miao, Ziqi Yuan, Shijia Zhang, Guangqin Zhang
Honokiol alleviates monosodium urate-induced gouty pain by inhibiting voltage-gated proton channels in mice. Inflammopharmacology 32 (4) (2024)
Anton D Van Staden
The potential of zebrafish as drug discovery research tool in immune-mediated inflammatory disease. Inflammopharmacology 32 (4) (2024)
Almudena Rodríguez-Fernández, Irene Visos-Varela, Maruxa Zapata-Cachafeiro, Samuel Pintos-Rodríguez, Rosa María García-Álvarez, María Teresa Herdeiro, María Piñeiro-Lamas, Adolfo Figueiras, Ángel Salgado-Barreira, null null
Outpatient glucocorticoid use and COVID-19 outcomes: a population-based study. Inflammopharmacology 32 (4) (2024)
Amanda Favarin, Gabriela Becker, Evelyne Silva Brum, Patrick Tuzi Serafini, Lara Panazzolo Marquezin, Indiara Brusco, Sara Marchesan Oliveira
Topical diosmetin attenuates nociception and inflammation in a ultraviolet B radiation-induced sunburn model in mice. Inflammopharmacology 32 (4) (2024)
Farzane Fereidouni, Ladan Kashani, Fardin Amidi, Mahshad Khodarahmian, Shahrzad Zhaeentan, Negar Ajabi Ardehjani, Tayebeh Rastegar
Astaxanthin treatment decreases pro-inflammatory cytokines and improves reproductive outcomes in patients with polycystic ovary syndrome undergoing assisted reproductive technology: A randomized clinical trial. Inflammopharmacology 32 (4) (2024)
Ibrahim Chaaban, Haidy Hafez, Aly Hazzaa, Souraya A Domiati, Khaled H Abd El Galil, Fadi Hdeib, Ahmed S F Belal, Hanan Ragab
Experimental investigation and molecular simulations of quinone related compounds as COX/LOX inhibitors. Inflammopharmacology 32 (4) (2024)
Nabeela Tabassum Sial, Abdul Malik, Urooj Iqbal, Malik Hassan Mehmood, Muhammad Fayyaz Ur Rehman
Novel antiarthritic mechanisms of Azelaic acid against CFA-induced arthritis in rats by modulating pro- and anti-inflammatory cytokines network. Inflammopharmacology 32 (4) (2024)
Niusha Esmaealzadeh, Mahdis Sadat Miri, Helia Mavaddat, Amirreza Peyrovinasab, Sara Ghasemi Zargar, Shirin Sirous Kabiri, Seyed Mehrad Razavi, Amir Hossein Abdolghaffari
The regulating effect of curcumin on NF-κB pathway in neurodegenerative diseases: a review of the underlying mechanisms. Inflammopharmacology 32 (4) (2024)
Abdul Mannan Baig, Sandy Rosko, Beate Jaeger, Joachim Gerlach, Hans Rausch
Unraveling the enigma of long COVID: novel aspects in pathogenesis, diagnosis, and treatment protocols. Inflammopharmacology 32 (4) (2024)
Yujin Wang, Xue Zhao, Yifei Gao, Chenxi Zhao, Jingxin Li, Shuanglian Wang, Bing Xue, Chuanyong Liu, Xuelian Ma
4-Octyl itaconate alleviates dextran sulfate sodium-induced ulcerative colitis in mice via activating the KEAP1-NRF2 pathway. Inflammopharmacology 32 (4) (2024)
Padmini Pai, Aradhika Vijeev, Sharada Phadke, Manasa Gangadhar Shetty, Kampa Sundara Babitha
Epi-revolution in rheumatology: the potential of histone deacetylase inhibitors for targeted rheumatoid arthritis intervention. Inflammopharmacology 32 (4) (2024)
Mengye Wu, Cuiping Li, Xue Zhou, Zhiyong Wu, Jianqi Feng, Xiaolu Guo, Rui Fang, Qinghai Lian, Ming Pan, Xiaorong Lai, Yanwen Peng
Wogonin preconditioning of MSCs improved their therapeutic efficiency for colitis through promoting glycolysis. Inflammopharmacology 32 (4) (2024)
Zhuo Wang, Chao Gao, Lei Zhang, Rubo Sui
Novel combination of Olesoxime/Resveratrol-encapsulated exosomes to improve cognitive function by targeting amyloid β-induced Alzheimer's disease: investigation on in vitro and in vivo model. Inflammopharmacology 32 (4) (2024)
Amany Abd Elaal Aiad, Sahar Mohamed El-Haggar, Amal Mohamed El-Barbary, Dalia Refat El-Afify
Metformin as adjuvant therapy in obese knee osteoarthritis patients. Inflammopharmacology 32 (4) (2024)
Hoda A Abd-Ellatieff, Kristen Georg, Abdel-Rahman A Abourawash, Emad W Ghazy, Dalia H Samak, Wael M Goda
Aspergillus awamori: potential antioxidant, anti-inflammatory, and anti-apoptotic activities in acetic acid-induced ulcerative colitis in rats. Inflammopharmacology 32 (4) (2024)
Behzad Einollahi, Mohammad Javanbakht, Mehrdad Ebrahimi, Mohammad Ahmadi, Morteza Izadi, Sholeh Ghasemi, Zahra Einollahi, Bentolhoda Beyram, Abolfazl Mirani, Ehsan Kianfar
Surveying haemoperfusion impact on COVID-19 from machine learning using Shapley values. Inflammopharmacology 32 (4) (2024)
Padmini Pai, Aradhika Vijeev, Sharada Phadke, Manasa Gangadhar Shetty, Kampa Sundara Babitha
Epi-revolution in rheumatology: the potential of histone deacetylase inhibitors for targeted rheumatoid arthritis intervention. Inflammopharmacology 32 (4) (2024)
S Rohini, Uday Raj Sharma, M Vinutha, D Shreelaxmi, Surendra Vada, Suresh Janandri, T Haribabu, Nageena Taj, S V Gayathri, Abhishek Ghara, Manjunatha P Mudagal
Rheumatoid arthritis-associated complications during pregnancy and its effect on offspring: comprehensive review. Inflammopharmacology 32 (4) (2024)
Jianwu Huang, Wenlong Kuang, Zihua Zhou
IL-1 signaling pathway, an important target for inflammation surrounding in myocardial infarction. Inflammopharmacology 32 (4) (2024)